Table 1.
Demographic and laboratory characteristics of STEMI patients.
| Characteristics (n = 27) | Results |
|---|---|
| Age, yrs. | 61.55 ± 14.51 |
| Female (%) | 44 |
| LVEF | 59.29 ± 13.07 |
| Body mass index, kg/m 2 | 28.48 ± 5.08 |
| Comorbidity (%) | |
| Hypertension (%) | 30 |
| Diabetes mellitus (%) | 15 |
| Current smoker (%) | 22 |
| Dyslipidemia (%) | 37 |
| Hx of CAD (%) | 7 |
| Laboratory data | |
| TG, mmol/l | 1.9 ± 1.65 |
| TC, mmol/l | 4.69 ± 1.27 |
| HDL-C, mmol/l | 1.14 ± 0.33 |
| LDL-C, mmol/l | 2.84 ± 1.06 |
| CR, mmol/l | 92.33 ± 43.97 |
| Additional parameters* | |
| Minutes from onset of chest pain to reperfusion | 140 [50–360] |
| Peak CK (Units/L) | 1017 [136–7028] |
| Peak TnT (ng/L) | 1862 [503–10000] |
| Culprit vessel (%) | |
| LAD Infarct (%) | 37 |
| RCA Infarct (%) | 48 |
| Circumflex Infarct (%) | 19 |
| Medications at baseline (%) | |
| ASA | 100 |
| Intravenous heparin | 100 |
| ACEI/ARB | 15 |
| Beta blocker | 7 |
| Statin | 15 |
| Ticagrelor | 96 |
| Clopidorgrel | 4 |
Values are mean ± SD or percent of patients otherwise specified.
*Median [Range].
GP IIb/IIIa inhibitors were not used in this cohort.
LVEF = left ventricular ejection fraction; Hx of CAD = history of coronary artery disease; TG = triglyceride; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; CR = creatinine; CK = creatine kinase; TnT = troponin; LAD = Left Anterior Descending coronary artery; RCA = Right coronary artery; ASA = Acetylsalicylic acid; ACEI = Angiotensin-converting enzyme (ACE) inhibitors; ARB = Angiotensin II receptor blockers.